LZM Patent Office
10 Ava Road Ava Tower # 19-07 Singapore 329949 (http://www.ycec.com )
Tel: 65 63533647 Fax: 65
62585636 Email: lzmyc@singnet.com.sg
Austrian Patent Office
Service and Information Center Email: Walter.Tomaschitz@patent.bmwa.gv.at
Division Manager
Urgent! Oct.13, 2003
Dear
Fax:
+43 1 534 24-733
Mag. Walter Tomaschitz;
Tel: +43 1 534
24-711
I had received your important notification on
Oct. 20, 2003.
The notification was that they refuse make a search report for my application of PCT/SG03/00145. The notification had stated a reason that:
“The applicant is hereby notified that no international search will be
established and that the declaration under Article 17(2)(a) to that effect is
transmitted herewith.”
In view the Article 17(2)(a):
(2)(a) If the International Searching
Authority considers
(i) that the international application relates to a subject matter which the
International Searching Authority is not required, under the Regulations, to
search, and in the particular case decides not to search, or
(ii) that the description, the claims, or the drawings, fail to comply with the
prescribed requirements to such an extent that a meaningful search could not be
carried out, the said Authority shall so declare and shall notify the applicant
and the International Bureau that no international search report will be
established.
Applicant
found that your department had abused the above legal stipulation, as you
did not to point out that my application of the description, the claims, or the
drawings had failed to comply with the prescribed requirement such that a
search could not be carried out! Our
claims are below:
1. The
main characteristic of the “Surface Treatment of SARS–Infected Lungs” is to
inject
sterilizing
liquid into the lung lobes.
2.
The formal name for the medicine of sterilizing liquid is Per
Fluoro Chemicals (PFC) adding
ozone forming a medicine.
3.
Including any other lung diseases and SARS inflammation.
4.
To add antibiotics or other bactericide into the
sterilizing liquid to suppress or to kill the virus.
In your Email that was sent on Oct. 22, 2003 had shown that you
thinks that my invention is a methods for treatment of the human and hence to
seek for a protection aimed at a second medical indication is not possible as
the injection of the above agent into the patient’s lung apparently constitutes
the sole inventive step of the present application. In my second reply, I had to
again point out that my application of subject matte is a liquid-medicine,
the medicine by PFC and O3 mixed together only.
In the such the US patent law, the methods for treatment of the human
can be accepted but other countries of patent laws that does not use same
medical method to prevent the second medical indication to get the patent if
subject matte no same my medicine by PFC and O3 mixed together. The
claims olso can change by the patent Examiner or inventor in defense
too, therefore, the search report can not have
any excuse!
Applicant once more to point out that your worried was needless
and your decision was a kind of prejudice as well as harms to my
application. Search for the liquid-medicine by PFC and O3 are your
responsibility, you can remind the patent examination of national for
solicitude of patent on report statement your view, but you can not to hurt the
benefit of inventor.
Please reply as soon as possible! Please Email to: lzmyc@singnet.com.sg
& ycec@163.net or Fax : 86 755 25550197 today !
Yours faithfully,
applicant : Lin Zhen Man
PCT/SG03/00145
Oct.29, 2003
cc. Intellectual
Property Office of Singapore
Fax : 6339 9230
Miss Tan Kar-Leng
of Registry of Patents:
Tel : 6331 654